74 related articles for article (PubMed ID: 8591078)
1. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.
Macdonald JS; Fleming TR; Peterson RF; Berenberg JL; McClure S; Chapman RA; Eyre HJ; Solanki D; Cruz AB; Gagliano R
Ann Surg Oncol; 1995 Nov; 2(6):488-94. PubMed ID: 8591078
[TBL] [Abstract][Full Text] [Related]
2. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
[TBL] [Abstract][Full Text] [Related]
3. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.
Lu Y; Pan W; Deng S; Dou Q; Wang X; An Q; Wang X; Ji H; Hei Y; Chen Y; Yang J; Zhang HM
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111268
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren's Classification in Pan-Cancer Analysis Era?
Zurlo IV; Basso M; Strippoli A; Calegari MA; Orlandi A; Cassano A; Di Salvatore M; Garufi G; Bria E; Tortora G; Barone C; Pozzo C
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630186
[No Abstract] [Full Text] [Related]
5. Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.
Ramos MFKP; de Castria TB; Pereira MA; Dias AR; Antonacio FF; Zilberstein B; Hoff PMG; Ribeiro U; Cecconello I
J Gastrointest Surg; 2020 Jan; 24(1):19-27. PubMed ID: 31745892
[TBL] [Abstract][Full Text] [Related]
6. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study.
Huang Z; Li S; Yang X; Lu F; Huang M; Zhang S; Xiong Y; Zhang P; Si J; Ma Y; Yang Y
Cancer Manag Res; 2019; 11():1299-1308. PubMed ID: 30799956
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Cirqueira CDS; de Mello ES; Zilberstein B; Alves VAF; Ribeiro U
Chin J Cancer Res; 2018 Oct; 30(5):526-536. PubMed ID: 30510364
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Zhuang J; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
Front Pharmacol; 2018; 9():929. PubMed ID: 30210338
[No Abstract] [Full Text] [Related]
10. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
[TBL] [Abstract][Full Text] [Related]
12. "Magic" of our gastric cancer results on perioperative chemotherapy.
León-Espinoza C; López-Mozos F; Marti-Obiol R; Garces-Albir M; Ortega-Serrano J
World J Gastrointest Pathophysiol; 2016 Aug; 7(3):283-7. PubMed ID: 27574566
[TBL] [Abstract][Full Text] [Related]
13. Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study.
Lee JY; Son T; Cheong JH; Hyung WJ; Noh SH; Kim CB; Park CG; Kim HI
J Gastric Cancer; 2015 Dec; 15(4):223-30. PubMed ID: 26819801
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy for gastric cancer: current evidence and future directions.
Newton AD; Datta J; Loaiza-Bonilla A; Karakousis GC; Roses RE
J Gastrointest Oncol; 2015 Oct; 6(5):534-43. PubMed ID: 26487948
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.
Choi YY; Noh SH; Cheong JH
Yonsei Med J; 2015 Sep; 56(5):1177-85. PubMed ID: 26256958
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.
Haneder S; Budjan JM; Schoenberg SO; Konstandin S; Schad LR; Hofheinz RD; Gramlich V; Wenz F; Lohr F; Boda-Heggemann J
Strahlenther Onkol; 2015 Apr; 191(4):356-64. PubMed ID: 25445156
[TBL] [Abstract][Full Text] [Related]
17. What make differences in the outcome of adjuvant treatments for resected gastric cancer?
Nakajima T; Fujii M
World J Gastroenterol; 2014 Sep; 20(33):11567-73. PubMed ID: 25206264
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.
Zhang YW; Zhang YL; Pan H; Wei FX; Zhang YC; Shao Y; Han W; Liu HP; Wang ZY; Yang SH
World J Gastroenterol; 2014 Jan; 20(2):584-92. PubMed ID: 24574729
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.
Ruf C; Thomusch O; Goos M; Makowiec F; Illerhaus G; Ruf G
BMC Surg; 2014 Jan; 14():5. PubMed ID: 24461063
[TBL] [Abstract][Full Text] [Related]
20. Basal renal function reserve and mean kidney dose predict future radiation-induced kidney injury in stomach cancer patients.
Yavas G; Elsurer R; Yavas C; Ata O
Support Care Cancer; 2014 Feb; 22(2):445-51. PubMed ID: 24197055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
